索引于
  • 打开 J 门
  • Genamics 期刊搜索
  • 引用因子
  • 宇宙IF
  • 西马戈
  • 乌尔里希的期刊目录
  • 电子期刊图书馆
  • 参考搜索
  • 哈姆达大学
  • 亚利桑那州EBSCO
  • 期刊摘要索引目录
  • OCLC-WorldCat
  • 普罗奎斯特传票
  • 学者指导
  • 虚拟生物学图书馆 (vifabio)
  • 普布隆斯
  • 日内瓦医学教育与研究基金会
  • 谷歌学术
分享此页面
期刊传单
Flyer image

抽象的

Does Nitric Oxide (NO) and/or Superoxide (.O2-) Cause Type 2 Diabetes and can it be Prevented?

Knox Van Dyke, Erica Ghareeb, Mark Van Dyke, Chris Van Dyke, Michael Gunther and David H Van Thie

Diabetes 2 is caused by metabolic effects on the pancreatic ß cells with loss of insulin sensitivity or effectiveness and control of its secretion. Some damage to the Beta cells probably occurs continuously once the disease process starts and oxidative and nitrosative stresses likely play a role as well caused by the proper lack of glucose control. Recent work indicates that excessive glucagon from alpha cells which replace Beta cells have an important role raising glucose levels. If this scenario is correct, specific antioxidant substances might have an important potential to quench, degrade or react with the key substances causing oxidative stress via oxidation/nitration processes causing chemically induced diabetes namely, superoxide (.O2 )-, nitric oxide (NO. ), peroxynitrite (OONO- ), etc. This pre-exposure may be able to prevent type 2 diabetes mellitus and/or its clinical consequences. Previously we found that correct doses of carboxy-PTIO (sodium salt) prevented diabetes mellitus I caused by Streptozotocin (STZ) in rats. Carboxy -PTIO oxidizes excessive nitric oxide from STZ occurring in the Beta cell. An intermediate dose of (STZ) in rats should partially mimic a type 2 diabetic state (glucose levels approx 300 mg/dl vs. 100 mg/dl in normal animals. We added effective antioxidants tempol and acetaminophen to prevent any excessive oxidative damage from STZ

免责声明: 此摘要通过人工智能工具翻译,尚未经过审核或验证